IL6 and type 2 diabetes mellitus: Given IL-6’s position in the cytokine cascade as a key mediator of downstream inflammatory processes including activation of coagulation, hepatic release of acute phase reactant proteins, IL-6 may have a potential causal role in metabolic risk factors associated with type 2 diabetes and cardiovascular disease.